Heterogeneity in Clinical Practices for Post-Cardiotomy Extracorporeal Life Support: a Pilot Survey from the PELS-1 Multicenter Study

Silvia Mariani,Gabor Bari,Justine M Ravaux,Bas C T van Bussel,Maria Elena De Piero,Ann-Kristin Schaefer,Khalil Jawad,Matteo Pozzi,Antonio Loforte,Nikolaos Kalampokas,Agne Jankuviene,Erwan Flecher,Xiaotong Hou,Jeroen J H Bunge,Kogulan Sriranjan,Leonardo Salazar,Bart Meyns,Michael A Mazzeffi,Sacha Matteucci,Sandro Sponga,Kollengode Ramanathan,Alessandro Costetti,Francesco Formica,Pranya Sakiyalak,Antonio Fiore,Chistof Schmid,Giuseppe Maria Raffa,Roberto Castillo,I-Wen Wang,Jae-Seung Jung,Tomas Grus,Vin Pellegrino,Giacomo Bianchi,Matteo Pettinari,Alessandro Barbone,José P Garcia,Mariusz Kowalewski,Kiran Shekar,Glenn Whitman,Roberto Lorusso1, the PELS-1 Investigators

DOI: https://doi.org/10.1111/aor.14601

2023-06-23

Abstract:Background: High-quality evidence for post-cardiotomy extracorporeal life support (PC-ECLS) management is lacking. This study investigated the real-world PC-ECLS clinical practices. Methods: This cross-sectional, multi-institutional, international pilot survey explored center organization, anticoagulation management, left ventricular unloading, distal limb perfusion, PC-ECLS monitoring and transfusions practices. Twenty-nine questions were distributed among 34 hospitals participating in the Post-cardiotomy Extra-Corporeal Life Support Study. Results: Of the 32 centers [16 low-volume (50%); 16 high-volume (50%)] that responded, 16 (50%) had dedicated ECLS specialists. Twenty-six centers (81.3%) reported using additional mechanical circulatory supports. Anticoagulation practices were highly heterogeneous: 24 hospitals (75%) reported using patient's bleeding status as a guide, without a specific threshold in 54.2% of cases. Transfusion targets ranged 7-10 g/dL. Most centers used cardiac venting on a case-by-case basis (78.1%) and regular distal limb perfusion (84.4%). Nineteen (54.9%) centers reported dedicated monitoring protocols including daily echocardiography (87.5%), Swan-Ganz catheterization (40.6%), cerebral near-infrared spectroscopy (53.1%) and multimodal assessment of limb ischemia. Inspection of the circuit (71.9%), oxygenator pressure drop (68.8%), plasma free hemoglobin (75%), d-dimer (59.4%), lactate dehydrogenase (56.3%) and fibrinogen (46.9%) are used to diagnose hemolysis and thrombosis. Conclusions: This study shows remarkable heterogeneity in clinical practices for PC-ECLS management. More standardized protocols and better implementation of available evidence are recommended.